ReviewNeuropsychiatric disease and treatment2019

A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy.

Daye Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.